medigraphic.com
ISSN 2307-2113 (Digital)
Revista Cubana de Información en Ciencias de la Salud (ACIMED)

2021, Número 3

<< Anterior Siguiente >>

Revista Cubana de Información en Ciencias de la Salud (ACIMED) 2021; 32 (3)


Mapeo de búsquedas electrónicas de las drogas más populares en la pandemia COVID-19 en Brasil

Ferreira NV, Yuri HT, Pereira TTAC, Barreto LM

Idioma: Portugués
Referencias bibliográficas: 63
Paginas: 1-28
Archivo PDF: 560.42 Kb.


RESUMEN

El estudio tuvo como objetivo mapear las búsquedas electrónicas de los medicamentos más populares en la pandemia COVID-19 en Brasil. Se trata de un estudio exploratorio, retrospectivo y mixto. Los datos fueron recolectados en julio de 2020 a través de Google Trends®. Se seleccionaron en los últimos 90 días de investigación los que estaban relacionados con los medicamentos ivermectina, cloroquina, hidroxicloroquina, dexametasona y azitromicina. Para identificar las noticias más visitadas se utilizó Google News®. La población brasileña realizó búsquedas electrónicas entre los cinco fármacos investigados, pero predominaron la cloroquina y la ivermectina. Además, a medida que la enfermedad evolucionó en los estados brasileños, la influencia de la investigación científica y gubernamental en la búsqueda de estos fármacos fue notable. Es de destacar que es fundamental para el manejo de la pandemia que se elaboren estrategias de comunicación, basadas en la responsabilidad social y la perspectiva del empoderamiento popular, con foco en la identificación de noticias falsas y el uso consciente de la información adquirida virtualmente.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Jenkins H. Cultura da Convergência. São Paulo: Aleph; 2009.

  2. Sousa Júnior JH, Raasch M, Soares JC, Ribeiro LVHAS. Da desinformação ao caos: uma análise das fake news frente à pandemia do Coronavírus (COVID-19) no Brasil. Cadernos de Prospecção. 2020;13(2):331-46. DOI: https://doi.org/10.9771/cp.v13i2.COVID-19.35978

  3. Le TT, Andreadakis Z, Kumar A, Román RG, Tollefsen S, Saville M, et al. The COVID-19 vaccine development landscape. Nat Rev Drug Discov. 2020;19(5):305-6. DOI: https://doi.org/10.1038/d41573.020.00073.5

  4. Jin Y, Yang H, Ji W, Wu W, Chen S, Zhang W, et al. Virology, Epidemiology, Pathogenesis, and Control of COVID-19. Viruses. 2020;12(4):372. DOI: https://doi.org/10.3390/v12040372

  5. Sanders JM, Monogue ML, Jodlowski TZ, Cutrell JB. Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): A Review. JAMA. 2020;323(18):1824-36. DOI: https://doi.org/10.1001/jama.2020.6019

  6. Moolla Y, Adam A, Perera M, Lawrentschuk N. Prostate cancer information on the Internet: fact or fiction? Curr Urol. 2020;13(4):200-8. DOI: https://doi.org/10.1159/000499271

  7. Cuan-Baltazar JY, Muñoz-Pérez MJ, Robledo-Vega C, Pérez-Zepeda MF, Soto-Vega E. Misinformation of COVID-19 on the Internet: Infodemiology Study. JMIR Public Health Surveill. 2020;6(2):e18444. DOI: https://doi.org/10.2196/18444

  8. Chinazzi M, Davis JT, Ajelli M, Gioannini C, Litvinova M, Merler S, et al. The effect of travel restrictions on the spread of the 2019 novel coronavirus (COVID-19) outbreak. Science. 2020;368(6489):395-400. DOI: https://doi.org/10.1126/science.aba9757

  9. Katapally TR. A Global Digital Citizen Science Policy to Tackle Pandemics Like COVID-19. J Med Internet Res. 2020;22(5):e19357. DOI: https://doi.org/10.2196/19357

  10. Rovetta A, Bhagavathula AS. COVID-19. Related Web Search Behaviors and Infodemic Attitudes in Italy: Infodemiological Study. JMIR Public Health Surveill. 2020;6(2):e19374. DOI: https://doi.org/10.2196/19374

  11. Cabral ERM, Bonfada D, Melo MC, Cesar ID, Oliveira REM, Bastos TF, et al. Contribuições e desafios da Atenção Primária à Saúde frente à pandemia de COVID-19. Inter Am J Med Health. 2020;3:1-12. DOI: https://doi.org/10.31005/iajmh.v3i0.87

  12. Tapia L. COVID-19 and Fake News in the Dominican Republic. Am J Trop Med Hyg. 2020;102(6):1172-4. DOI: https://doi.org/10.4269/ajtmh.20.0234

  13. O'Connor C, Murphy M. Going viral: doctors must tackle fake news in the COVID-19 pandemic. BMJ. 2020;369:1587. DOI: https://doi.org/10.1136/bmj.m1587

  14. Daniel AE, Sewunet AB, Solomon A, Mahipal S, Jackson T, Kathryn JS, et al. When fear and misinformation go viral: Pharmacists' role in deterring medication misinformation during the 'infodemic' surrounding COVID-19. Res Social Adm Pharm. 2020;(20):30455-61. DOI: https://doi.org/10.1016/j.sapharm.2020.04.032

  15. Choudhary R, Sharma AK, Choudhary R. Potential use of hydroxychloroquine, ivermectin and azithromycin drugs in fighting COVID-19: trends, scope and relevance. New Microbes New Infect. 2020;35:100684. DOI: https://doi.org/10.1016/j.nmni.2020.100684

  16. Gautret P, Lagier JC, Parola P, Hoang VT, Meddeb L, Mailhe M, et al. Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open. 2020;56(1):105949. DOI: https://doi.org/10.1016/j.ijantimicag.2020.105949

  17. Caly L, Druce JD, Catton MG, Jans DA, Wagstaff KM. The FDA approved Drug Ivermectin inhibits the replication of SARS.CoV.2 in vitro. Antiviral Res. 2020;178:104787. DOI: https://doi.org/10.1016/j.antiviral.2020.104787

  18. Passos JÁ, Vasconcellos-Silva PR, Santos LAS. Ciclos de atenção a dietas da moda e tendências de busca na internet pelo Google trends. Cien Saude Colet. 2020;25(7):2615-31. DOI: https://doi.org/10.1590/1413.81232020257.23892018

  19. Erbolato ML. Técnicas de codificação em jornalismo - redação, captação e edição no jornal diário. São Paulo: Ática; 1991.

  20. Mota JS. Utilização do google forms na pesquisa acadêmica. Rev Humanidad Inov. 2019 [acesso: 22/07/2020];6(12):371-80. Disponível em: Disponível em: https://revista.unitins.br/index.php/humanidadeseinovacao/article/view/1106

  21. Samaras L, García Barriocanal E, Sicilia MA. Comparing Social media and Google to detect and predict severe epidemics. Sci Rep. 2020;10(1):4747. DOI: https://doi.org/10.1038/s41598.020.61686.9

  22. Xu X, Ong YK, Wang DY. Role of adjunctive treatment strategies in COVID-19 and a review of international and national clinical guidelines. Mil Med Res. 2020;7(1):22. DOI: https://doi.org/10.1186/s40779.020.00251.x

  23. Ribeiro TB, Mazotti TA, Nobre MRC, Stein A, De Melo DO. Iniciativas brasileiras de estudos de intervenção em andamento para a COVID-19. Home Health Sciences [Preprint]; 2020. DOI: https://doi.org/10.1590/SciELOPreprints.45

  24. Molento MB. COVID-19 and the rush for self.medication and self. dosing with ivermectin: A word of caution. One Health. 2020;10:100148. DOI: https://doi.org/10.1016/j.onehlt.2020.100148

  25. Shah S, Das S, Jain A, Misra DP, Negi VS. A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19). Int J Rheum Dis. 2020 [Pré.impressão]. DOI: https://doi.org/10.1111/1756.185X.13842

  26. Wang M, Cao R, Zhang L, Yang X, Liu J, Shi Z, et al. Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019.nCoV) in vitro. Cell Res. 2020;30(3):269-71. DOI: https://doi.org/10.1038/s41422.020.0282.0

  27. Borba MGS, Val FFA, Sampaio VS, Alexandre MAA, Melo GC, Brito M, et al. Effect of High vs. Low Doses of Chloroquine Diphosphate as Adjunctive Therapy for Patients Hospitalized With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS.CoV.2) Infection: A Randomized Clinical Trial. JAMA New Open. 2020;3(4):e208857. DOI: https://doi.org/10.1001/jamanetworkopen.2020.8857

  28. Badyal DK, Mahajan R. Chloroquine: Can it be a Novel Drug for COVID-19. Int J Appl Basic Med Res. 2020;10(2):128-30. DOI: https://doi.org/10.4103/ijabmr.IJABMR_141_20

  29. COVID-19 Treatment Guidelines Panel. Coronavirus Disease 2019 (COVID-19) Treatment Guidelines. National Institutes of Health (NHI); 2020 [acesso: 11/08/2020]. Disponível em: Disponível em: https://www.covid19treatmentguidelines.nih.gov/

  30. Center for Disease Control (CDC). Information for Clinicians on Investigational Therapeutics for Patients with COVID-19. CDC; 2020 [acesso:11/10/2020]. Disponível em: Disponível em: https://www.cdc.gov/coronavirus/2019.ncov/hcp/therapeutic.options.html#r8

  31. Lenzer J. Covid-19: US gives emergency approval to hydroxychloroquine despite lack of evidence. BMJ. 2020;369:1335. DOI: https://doi.org/10.1136/bmj.m1335

  32. Indian Council of Medical Research. Advisory on the use of hydroxychloroquine as prophylaxis for SARS.CoV.2 infection. New Delhi: ICMR; 2020 [acesso: 19/07/2020]. Disponível em: https://www.mohfw.gov.in/pdf/AdvisoryontheuseofHydroxychloroquinasprophylaxisforSARSCoV2infection.pdf

  33. National Health Commission of the People's Republic of China. Novel Coronavirus Pneumonia Diagnosis and Treatment Plan. National Health Commission of the People's Republic of China; 2020 [acesso: 19/07/2020]. Disponível em: Disponível em: https://wwwchinalawtranslatecom/en/diagnostic.and.treatment.plan.6/

  34. Food Drug Administration (FDA). Coronavirus (COVID-19) Update: Daily Roundup. Food Drug Administration (FDA); 2020 [acesso: 19/07/2020]. Disponível em: Disponível em: https://www.fda.gov/news.events/press.announcements/coronavirus.COVID-19.update.daily.roundup.march.30.2020

  35. Smith T, Prosser T. COVID-19 drug therapy potential options. Elsevier; 2020. [acesso: 27/07/2020]. Disponível em: Disponível em: https://www.elsevier.com/__data/assets/pdf_file/0006/991014/Test.doc.do.se.if.url.changes.on.replacement.upload.pdf

  36. Boulware DR, Pullen MF, Bangdiwalav AS, Pastick KA, Lofgren SM, Okafor EC, et al. A Randomized Trial of Hydroxychloroquine as Postexposure Prophylaxis for Covid-19. N Engl J Med. 2020 [acesso: 12/08/2020];383(6):517-25. DOI: https://doi.org/10.1056/NEJMoa2016638

  37. Horby P, Mafham M, Linsell L, Bell JL, Staplin N, Emberson JR, et al. Effect of Hydroxychloroquine in Hospitalized Patients with COVID-19: Preliminary results from a multi.centre, randomized, controlled trial. medRxiv (Pré.impressão); 2020 [acesso: 12/08/2020]. DOI: https://doi.org/10.1101/2020.07.15.20151852

  38. Ledford H. Coronavirus breakthrough: dexamethasone is first drug shown to save lives. Nature. 2020 [acesso: 22/07/2020];582(7813):469. DOI: https://doi.org/10.1038/d41586.020.01824.5

  39. Singh AK, Majumdar S, Singh R, Misra A. Role of corticosteroid in the management of COVID-19: A systemic review and a Clinician's perspective. Diabetes Metab Syndr. 2020 [acesso: 28/07/2020];14(5):971-8. DOI: https://doi.org/10.1016/j.dsx.2020.06.054

  40. Walker A, Hopkins C, Surda P. Use of Google Trends to investigate loss-of-smell-related searches during the COVID-19 outbreak. Int Forum Allergy Rhinol. 2020 [acesso: 15/08/2020];10(7):839-47. DOI: https://doi.org/10.1002/alr.22580

  41. Schmith VD, Zhou JJ, Lohmer LRL. The Approved Dose of Ivermectin Alone is not the Ideal Dose for the Treatment of COVID-19. Clin Pharmacol Ther [Pré.impressão]. 2020 [acesso: 12/07/2020]. DOI: https://doi.org/10.1002/cpt.1889

  42. Momekov G, Momekova D. Ivermectin as a potential COVID-19 treatment from the pharmacokinetic point of view: antiviral levels are not likely attainable with known dosing regimens. Biotechnol Biotechnol Equip. 2020 [acesso: 10/07/2020];34(1):469-74. DOI: https://doi.org/10.1080/13102818.2020.1775118

  43. Bray M, Rayner C, Noël F, Jans D, Wagstaff K. Ivermectin and COVID-19: A report in Antiviral Research, widespread interest an FDA warning, two letters to the editor and the authors' responses. Antiviral Res. 2020 [acesso: 14/07/2020];178:104805. doi: https://doi.org/10.1016/j.antiviral.2020.104805

  44. Espinosa MM, Oliveira EC, Melo JS, Damaceno RD, Terças. Trettel ACP. Predição de casos e óbitos de COVID-19 em Mato Grosso e no Brasil. J Health Biol Sci. 2020 [acesso: 16/08/2020];8(1):1-7. DOI: https://doi.org/10.12662/2317.3206jhbs.v8i1.3224.p1.7.2020

  45. Onchonga D. A Google Trends study on the interest in self.medication during the 2019 novel coronavirus (COVID-19) disease pandemic. Saudi Pharm J. 2020 [acesso: 02/08/2020];28(7):903-4. doi: https://doi.org/10.1016/j.jsps.2020.06.007

  46. Bento AI, Nguyen T, Wing C, Lozano-Rojas F, Ahn YY, Simon K. Evidence from internet search data shows information-seeking responses to news of local COVID-19 cases. Proc Natl Acad Sci EE.UU. 2020 [acesso: 10/07/2020];117(21):11220-2. DOI: https://doi.org/10.1073/pnas.2005335117

  47. Ministério da Saúde. Centro de operações de emergência em Saúde Pública - COVID-19. Brasília: Ministério da Saúde; 2020 [acesso: 10/07/2020]. Disponível em: Disponível em: http://www.covid.saude.gov.br

  48. Noronha KVMS, Guedes GR, Turra CM, Andrade MV, Botega L, Nogueira D, et al. Pandemia por COVID-19 no Brasil: análise da demanda e da oferta de leitos hospitalares e equipamentos de ventilação assistida segundo diferentes cenários. Cad Saude Publ. 2020 [acesso: 01/11/2020];36(6):e00115320. DOI: https://doi.org/10.1590/0102.311X00115320

  49. De Lima DMDF, Silva MASD, Santos ESD. Fase inicial da pandemia da COVID-19 em mato grosso: distribuição espacial e avaliação. Rev Bras Geogr Méd Saúde. 2020 [acesso: 15/08/2020];312:320. DOI: https://doi.org/10.14393/Hygeia0054634

  50. Baqui P, Bica I, Marra V, Ercole A, Van Der Schaar M. Ethnic and regional variations in hospital mortality from COVID-19 in Brazil: a cross.sectional observational study. Lancet Glob Health. 2020 [acesso: 19/08/2020];8(8):e1018-26. DOI: https://doi.org/10.1016/S2214.109X(20)30285.0

  51. Mavragani A. Tracking COVID-19 in Europe: Infodemiology Approach. JMIR Public Health Surveill. 2020 [acesso: 05/06/2020];6(2):e18941. DOI: https://doi.org/10.2196/18941

  52. Husnayain A, Fuad A, Su E. Applications of Google Search Trends for risk communication in infectious disease management: A case study of the COVID-19 outbreak in Taiwan. Int J Infect Dis. 2020 [acesso: 13/06/2020];95:221-3. DOI: https://doi.org/10.1016/j.ijid.2020.03.021

  53. Rathore FA, Farooq F. Information Overload and Infodemic in the COVID-19 Pandemic. J Pak Med Assoc. 2020 [acesso: 14/07/2020];70(Suppl. 3):S162-5. DOI: https://doi.org/10.5455/JPMA.38

  54. Limaye RJ, Sauer M, Ali J, Bernstein J, Wahl B, Barnhill A, et al. Building trust while influencing online COVID-19 content in the social media world. Lancet Digit Health. 2020 [acesso: 10/06/2020];2(6):e277-8. DOI: https://doi.org/10.1016/S2589.7500(20)30084.4

  55. Chaccour C, Hammann F, Ramón,García S, Rabinovich NR. Ivermectin and COVID-19: Keeping Rigor in Times of Urgency. Am J Trop Med Hyg. 2020 [acesso: 10/08/2020];102(6):1156-7. DOI: https://doi.org/10.4269/ajtmh.20.0271

  56. Kalil AC. Treating COVID-19 Off-Label Drug Use, Compassionate Use, and Randomized Clinical Trials During Pandemics. JAMA. 2020 [acesso: 19/06/2020];323(19):1897-8. DOI: https://doi.org/10.1001/jama.2020.4742

  57. Neto M, Gomes TO, Porto FR, Rafael RMR, Fonseca MHS, Nascimento J. Fake news in the context of the COVID-19 pandemic. Cogitare Enferm. 2020 [acesso: 12/06/2020];25:[aprox. 7 p.]. DOI: https://doi.org/10.5380/ce.v25i0.72627

  58. Chatterjee R, Bajwa S, Dwivedi D, Kanji R, Ahammed M, Shaw R. COVID-19 Risk Assessment Tool: Dual application of risk communication and risk governance. Progr Disast Sci. 2020 [acesso: 15/08/2020];7:100109. DOI: https://doi.org/10.1016/j.pdisas.2020.100109

  59. Lellis MB, Moreira BD. Cultura Científica e o papel do Jornalismo Científico frente às Fakes News na ciência. Anais 42º Congresso Brasileiro de Ciências da Comunicação - Intercom; 2 a 7 de setembro de 2019; Belém. Pará: Intercom2019 [acesso: 11/08/2020]. Disponível em: Disponível em: https://portalintercom.org.br/anais/nacional2019/resumos/R14.0886.1.pdf

  60. Xavier F, Olenscki JRW, Acosta AL, Salllum MAM, Saraiva AM. Análise de redes sociais como estratégia de apoio à vigilância em saúde durante a COVID-19. Estud Av. 2020 [acesso: 17/07/2020];34(99):261-82. DOI: https://doi.org/10.1590/s0103.4014.2020.3499.016

  61. Ventura-Silva JMA, Ribeiro OMPL, Santos MR, Faria ACA, Monteiro MAJ, Vandresen L. Planejamento organizacional no contexto de pandemia por COVID-19: implicações para a gestão em enfermagem. J Health NPEPS. 2020 [acesso: 17/07/2020];5(1):e4626. DOI: https://doi.org/10.30681/252610104626

  62. Pereira MV, Alencar JS, Souto RP, Pinto NB, Saraiva SEM. Grau de conhecimento dos pacientes sobre o tratamento: estratégia para uso racional de medicamentos. J Health NPEPS. 2016 [acesso: 17/07/2020];1(1):31-9. Disponível em: Disponível em: https://periodicos.unemat.br/index.php/jhnpeps/article/view/1557

  63. Dantas TP, Aguiar CAS, Rodrigues VRT, Silva RRG, Silva MIC, Sampaio LRL, et al. Diagnósticos de enfermagem para pacientes com COVID-19. J Health NPEPS. 2020 [acesso: 17/07/2020];5(1):396-416. DOI: https://doi.org/10.30681/252610104575




2020     |     www.medigraphic.com